Clinical Trial Update: Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated Granulocyte-Macrophage Stimulating Factor (GM-CSF) for the treatment of Peripheral Arterial Disease; results from the completed study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Granulocyte-Macrophage Stimulating Factor (GM-CSF)

Snippet

Sponsor: Emory University | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-12-23